![Clinical Trial Results. org The ERASE Trial: Effect of rHDL on Atherosclerosis-Safety and Efficacy Presented at American College of Cardiology Annual Scientific. - ppt download Clinical Trial Results. org The ERASE Trial: Effect of rHDL on Atherosclerosis-Safety and Efficacy Presented at American College of Cardiology Annual Scientific. - ppt download](https://slideplayer.com/9/2521450/big_thumb.jpg)
Clinical Trial Results. org The ERASE Trial: Effect of rHDL on Atherosclerosis-Safety and Efficacy Presented at American College of Cardiology Annual Scientific. - ppt download
ASCO GU 2022: Efficacy and Safety of Lenvatinib Plus Pembrolizumab Versus Sunitinibin the East Asian Subset of Patients With Advanced Renal Cell Carcinoma From the Phase 3 CLEAR Trial
![High Intensity Training regimen may inhibit prostate cancer growth — ERASE trial - Juta MedicalBrief High Intensity Training regimen may inhibit prostate cancer growth — ERASE trial - Juta MedicalBrief](https://www.medicalbrief.co.za/wp-content/uploads/2021/09/7-MB-Editors-Picks-02-09-2021-1-Exercise-Gym-Man-Intensity-Training-Jump-iStock-1136434170.jpg)
High Intensity Training regimen may inhibit prostate cancer growth — ERASE trial - Juta MedicalBrief
![ASCO 2021: Post Hoc Analysis of the CLEAR Study in Advanced Renal Cell Carcinoma (RCC): Effect of Subsequent Therapy on Survival Outcomes in the Lenvatinib (LEN) + Everolimus (EVE) Versus Sunitinib (SUN) ASCO 2021: Post Hoc Analysis of the CLEAR Study in Advanced Renal Cell Carcinoma (RCC): Effect of Subsequent Therapy on Survival Outcomes in the Lenvatinib (LEN) + Everolimus (EVE) Versus Sunitinib (SUN)](https://www.urotoday.com/images/CLEAR_trial.png)
ASCO 2021: Post Hoc Analysis of the CLEAR Study in Advanced Renal Cell Carcinoma (RCC): Effect of Subsequent Therapy on Survival Outcomes in the Lenvatinib (LEN) + Everolimus (EVE) Versus Sunitinib (SUN)
![A Randomized Trial of the Effects of Exercise on Anxiety, Fear of Cancer Progression and Quality of Life in Prostate Cancer Patients on Active Surveillance | Journal of Urology A Randomized Trial of the Effects of Exercise on Anxiety, Fear of Cancer Progression and Quality of Life in Prostate Cancer Patients on Active Surveillance | Journal of Urology](https://www.auajournals.org/cms/asset/4239f39e-0cb5-4ea9-b212-23b3f1291273/ju.0000000000002334f1.gif)
A Randomized Trial of the Effects of Exercise on Anxiety, Fear of Cancer Progression and Quality of Life in Prostate Cancer Patients on Active Surveillance | Journal of Urology
![ASCO 2021: Health-Related Quality-of-Life Analysis from the Phase 3 CLEAR Trial of Lenvatinib + Pembrolizumab or Everolimus Versus Sunitinib for Patients with Advanced RCC ASCO 2021: Health-Related Quality-of-Life Analysis from the Phase 3 CLEAR Trial of Lenvatinib + Pembrolizumab or Everolimus Versus Sunitinib for Patients with Advanced RCC](https://www.urotoday.com/images/ASCO_IV_Q3W.png)
ASCO 2021: Health-Related Quality-of-Life Analysis from the Phase 3 CLEAR Trial of Lenvatinib + Pembrolizumab or Everolimus Versus Sunitinib for Patients with Advanced RCC
![Exercise duRing Active Surveillance for prostatE cancer—the ERASE trial: a study protocol of a phase II randomised controlled trial | BMJ Open Exercise duRing Active Surveillance for prostatE cancer—the ERASE trial: a study protocol of a phase II randomised controlled trial | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/9/7/e026438/F3.large.jpg)
Exercise duRing Active Surveillance for prostatE cancer—the ERASE trial: a study protocol of a phase II randomised controlled trial | BMJ Open
![CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins? | Journal of the American Heart Association CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins? | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/87da567f-7889-4b7a-b46e-04501a42a525/jah34014-fig-0001.png)
CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins? | Journal of the American Heart Association
![American College of Cardiology on Twitter: "The CLEAR Wisdom trial showed that bempedoic acid is safe and effective in reducing LDL-C compared with placebo among patients with #ASCVD or heterogeneous FH on American College of Cardiology on Twitter: "The CLEAR Wisdom trial showed that bempedoic acid is safe and effective in reducing LDL-C compared with placebo among patients with #ASCVD or heterogeneous FH on](https://pbs.twimg.com/media/D3y0K-mW0AEr5CG.jpg)